OVERVIEW

BPC‑157, TB‑500, GHK‑Cu (Glow Blend) 30 mg is a combination of three synthetic peptides often marketed in research and cosmetic spaces for their distinct biological activities. BPC‑157 is a 15‑amino‑acid peptide derived from a protective gastric protein that has been studied in laboratory and animal models for potential roles in tissue repair, modulation of inflammation, and promotion of vascular growth. TB‑500 is a synthetic fragment of thymosin beta‑4 that research suggests may influence cell migration and tissue remodeling, which could support recovery processes in connective tissues. GHK‑Cu (Copper Peptide) is a tripeptide complexed with a copper ion that has drawn interest in cosmetic science for its role in signaling pathways tied to skin renewal and antioxidant defenses. In combination, this “Glow Blend” is formulated with about 30 mg of total peptide content and is often promoted for enhanced tissue support, wound recovery, and skin‑related benefits in experimental settings, though these effects come primarily from preclinical or small‑scale studies.

Despite its popularity in experimental and cosmetic communities, this peptide blend is not approved for medical use by the U.S. Food and Drug Administration, and robust clinical evidence in humans is limited. Products sold with these combinations are typically labeled “for research use only,” meaning purity, quality, and dosing consistency can vary widely between suppliers. Additionally, individual components such as BPC‑157 and TB‑500 are listed on the World Anti‑Doping Agency prohibited list for athletes due to potential performance‑enhancing effects, underscoring that use outside approved research environments carries ethical, legal, and safety concerns. Anyone curious about peptide blends should consult qualified healthcare professionals and rely on evidence‑based interventions rather than unregulated compounds.